• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马兜铃酸在兔体内的药代动力学及肾毒性

Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits.

作者信息

Chen Shih-Ming, Fan Mei-Yu, Tseng Chia-Chi, Ho Yih, Hsu Kuang-Yang

机构信息

School of Pharmacy, Department of Pharmaceutical Sciences, Taipei Medical University, 250 Wu-Hsing St., Taipei 110-31, Taiwan.

出版信息

Toxicon. 2007 Aug;50(2):180-8. doi: 10.1016/j.toxicon.2007.03.011. Epub 2007 Apr 1.

DOI:10.1016/j.toxicon.2007.03.011
PMID:17512963
Abstract

Aristolochic acids (AAs) which exist in plants of the genus Aristolochia are the toxins responsible for aristolochic acid nephropathy (AAN). To investigate the pharmacokinetics and nephrotoxicity of AAs, rabbits were used in this study. The plasma concentrations of the main components of AAs, aristolochic acid I (AA I) and aristolochic acid II (AA II), were determined by a validated high-performance liquid chromatographic method. After intravenous administration of different doses (0.25, 0.5, 1.0, and 2.0mg/kg) of aristolochic acid sodium (AANa) to 4 respective groups of rabbits (n=6 for each dose), linear relationships between the doses of AA I and AA II and the area under the plasma concentration curve (AUC) were found to exist (p<0.001). AANa was also given in escalating doses (0.5, 1.0, and 2.0mg/kg) to the same rabbits at 7-day intervals. The clearance rates of both AA I and AA II significantly decreased with the escalating dose (p<0.001). A nonlinear relationship between the dose and AUC was obtained. Kidney specimens of rabbits were obtained to observe morphological changes on days 1 and 7 after AANa administration. The renal lesions caused by AAs consisted of progressive and dose-dependent tubular damage. However, no remarkable changes in the morphology of glomeruli were observed.

摘要

马兜铃酸(AAs)存在于马兜铃属植物中,是导致马兜铃酸肾病(AAN)的毒素。为了研究马兜铃酸的药代动力学和肾毒性,本研究使用了兔子。采用经过验证的高效液相色谱法测定马兜铃酸主要成分马兜铃酸I(AA I)和马兜铃酸II(AA II)的血浆浓度。将不同剂量(0.25、0.5、1.0和2.0mg/kg)的马兜铃酸钠(AANa)分别静脉注射给4组兔子(每组剂量n = 6)后,发现AA I和AA II的剂量与血浆浓度曲线下面积(AUC)之间存在线性关系(p<0.001)。还以递增剂量(0.5、1.0和2.0mg/kg)每隔7天给同一只兔子注射AANa。随着剂量递增,AA I和AA II的清除率均显著降低(p<0.001)。得到了剂量与AUC之间的非线性关系。在注射AANa后第1天和第7天获取兔子的肾脏标本,观察形态学变化。马兜铃酸引起的肾脏病变包括进行性和剂量依赖性的肾小管损伤。然而,未观察到肾小球形态有明显变化。

相似文献

1
Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits.马兜铃酸在兔体内的药代动力学及肾毒性
Toxicon. 2007 Aug;50(2):180-8. doi: 10.1016/j.toxicon.2007.03.011. Epub 2007 Apr 1.
2
[Advances in studies on pharmacokinetics of aristolochic acid I].[马兜铃酸 I 的药代动力学研究进展]
Zhongguo Zhong Yao Za Zhi. 2006 Oct;31(19):1573-5.
3
Effects of rhein and Rheum palmatum L. extract on the pharmacokinetics and tissue distribution of aristolochic acid I and its demethylated metabolite in rats.大黄酸和大黄素对大鼠体内马兜铃酸 I 及其去甲基代谢物药代动力学和组织分布的影响。
J Ethnopharmacol. 2021 Mar 1;267:113537. doi: 10.1016/j.jep.2020.113537. Epub 2020 Nov 1.
4
The nephrotoxicity of Aristolochia manshuriensis in rats is attributable to its aristolochic acids.东北马兜铃对大鼠的肾毒性归因于其马兜铃酸。
Clin Exp Nephrol. 2003 Sep;7(3):186-94. doi: 10.1007/s10157-003-0229-z.
5
[Nephrotoxicity of Aristolochia manshuriensis and aristolochic acids in mice].[东北马兜铃及马兜铃酸对小鼠的肾毒性]
Zhongguo Zhong Yao Za Zhi. 2005 Jul;30(13):1019-22.
6
Localization of aristolochic acid in mouse kidney tissues by immunohistochemistry using an anti-AA-I and AA-II monoclonal antibody.应用抗 AA-I 和 AA-II 单克隆抗体的免疫组化方法检测小鼠肾组织中的马兜铃酸。
Am J Chin Med. 2014;42(6):1453-69. doi: 10.1142/S0192415X14500918.
7
Pharmacokinetics of p-Aminohippuric Acid and Inulin in Rabbits with Aristolochic Acid Nephropathy.马兜铃酸肾病家兔对氨基马尿酸和菊粉的药代动力学
Adv Pharmacol Sci. 2011;2011:204501. doi: 10.1155/2011/204501. Epub 2011 Jun 16.
8
Is aristolochic acid nephropathy a widespread problem in developing countries? A case study of Aristolochia indica L. in Bangladesh using an ethnobotanical-phytochemical approach.马兜铃酸肾病在发展中国家是一个普遍存在的问题吗?孟加拉国采用民族植物学-植物化学方法对马兜铃属植物进行的案例研究。
J Ethnopharmacol. 2013 Aug 26;149(1):235-44. doi: 10.1016/j.jep.2013.06.028. Epub 2013 Jun 24.
9
Selective toxicity of aristolochic acids I and II.马兜铃酸I和II的选择性毒性。
Drug Metab Dispos. 2007 Jul;35(7):1217-22. doi: 10.1124/dmd.107.014688. Epub 2007 Mar 28.
10
Increased renal semicarbazide-sensitive amine oxidase activity and methylglyoxal levels in aristolochic acid-induced nephrotoxicity.马兜铃酸诱导的肾毒性中,肾氨基脲敏感胺氧化酶活性和甲基乙二醛水平升高。
Life Sci. 2014 Sep 26;114(1):4-11. doi: 10.1016/j.lfs.2014.07.034. Epub 2014 Aug 8.

引用本文的文献

1
Comparative studies on the multi-component pharmacokinetics of Aristolochiae Fructus and honey-fried Aristolochiae Fructus extracts after oral administration in rats.大鼠口服马兜铃果实及蜜炙马兜铃果实提取物后多成分药代动力学的比较研究。
BMC Complement Altern Med. 2017 Feb 10;17(1):107. doi: 10.1186/s12906-017-1626-2.
2
Evaluating weight of evidence in the mystery of Balkan endemic nephropathy.评估巴尔干地方性肾病之谜中的证据权重。
Risk Anal. 2014 Sep;34(9):1688-705. doi: 10.1111/risa.12239. Epub 2014 Jun 20.
3
The safety of Homnawakod herbal formula containing Aristolochia tagala Cham. in Wistar rats.
含天仙藤的 Homnawakod 草药配方在 Wistar 大鼠中的安全性。
BMC Complement Altern Med. 2012 Oct 3;12:170. doi: 10.1186/1472-6882-12-170.
4
Pharmacokinetics of p-Aminohippuric Acid and Inulin in Rabbits with Aristolochic Acid Nephropathy.马兜铃酸肾病家兔对氨基马尿酸和菊粉的药代动力学
Adv Pharmacol Sci. 2011;2011:204501. doi: 10.1155/2011/204501. Epub 2011 Jun 16.
5
Activation of p53 promotes renal injury in acute aristolochic acid nephropathy.p53 的激活促进急性马兜铃酸肾病的肾损伤。
J Am Soc Nephrol. 2010 Jan;21(1):31-41. doi: 10.1681/ASN.2008111133. Epub 2009 Nov 5.